- In January 2024, CSL Behring, a division of the renowned biotechnology company CSL, made a 10g prefilled syringe for Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) accessible to the public. The Hizentra prefilled syringes enhance the treatment experience for individuals with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Primary Immunodeficiency (PI) by eliminating the requirement to extract medication from vials
- In October 2023, KTC Edibles, the leading provider of edible oils in the U.K., introduced Planet Palm, a fresh line of palm oil products that are certified sustainable, traceable, and sustainably produced. These products are specifically designed for food producers in the U.K.
- In September 2023, Grifols announced the expansion of its plasma collection network in North America, aiming to increase access to high-quality plasma for immunotherapy and other treatments
- In August 2023, CSL Behring launched a new high-purity immunoglobulin product, enhancing treatment options for patients with immune deficiencies and autoimmune diseases
